当前位置:首页 - 行情中心 - 凯赛生物(688065) - 财务分析 - 资产负债表

凯赛生物

(688065)

  

流通市值:299.27亿  总市值:299.27亿
流通股本:5.83亿   总股本:5.83亿

资产负债表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
流动资产:
货币资金4,987,762,122.155,390,218,174.985,819,930,024.966,166,816,815.09
应收票据及应收账款362,646,530.52306,119,845.4360,297,936.27359,198,551.79
其中:应收票据70,956,361.6362,863,954.2852,346,672.9391,679,596.1
应收账款291,690,168.89243,255,891.12307,951,263.34267,518,955.69
应收款项融资68,692,539.1379,402,948.0237,331,566.2437,495,692.82
预付款项58,700,922.4130,524,059.3758,344,530.5256,201,448.87
其他应收款合计8,764,040.8110,354,231.7311,349,473.38125,184,194.76
存货1,374,593,313.281,466,355,603.971,513,748,478.571,491,381,088.08
其他流动资产289,853,854.76287,224,097.38237,883,495.26189,151,062.36
流动资产平衡项目0000
流动资产合计7,151,482,571.067,570,668,208.858,039,354,753.28,425,898,101.77
非流动资产:
长期股权投资141,067,497.91142,732,325.97144,580,313.26146,744,240.77
投资性房地产--20,290,342.0420,628,425.25
固定资产3,867,977,934.883,932,720,470.53,722,759,572.383,667,141,624.88
在建工程5,673,666,796.245,443,065,405.954,848,791,523.143,992,260,211.9
无形资产698,840,188.62703,853,601.09703,173,341.09708,029,401.81
长期待摊费用6,477,992.084,976,883.252,706,626.3153,925,284.4
递延所得税资产168,971,446.5158,876,956.81111,670,855.0496,348,302.37
其他非流动资产909,259,335.94876,478,907.511,154,424,009.291,381,920,591.86
非流动资产平衡项目0000
非流动资产合计11,466,261,192.1711,262,704,551.0310,758,396,582.5510,066,998,083.24
资产平衡项目0000
资产总计18,617,743,763.2318,833,372,759.8818,797,751,335.7518,492,896,185.01
流动负债:
短期借款630,633,941.59746,254,035.09521,144,748.54475,678,425.08
应付票据及应付账款1,448,608,137.291,681,949,742.051,469,870,846.961,170,559,914.98
其中:应付票据30,000,00030,000,0006,966,3206,966,320
应付账款1,418,608,137.291,651,949,742.051,462,904,526.961,163,593,594.98
预收款项1,016,536.32,519,337.16--
合同负债27,937,855.4110,477,981.7418,323,413.9619,818,012.88
应付职工薪酬6,296,555.712,672,123.176,644,366.282,675,396.09
应交税费61,062,848.2265,467,715.0134,643,942.4638,386,491.94
其他应付款合计119,840,489.81102,701,219.66104,612,054.67203,478,927.64
应付股利831,600831,600-104,786,128.8
一年内到期的非流动负债454,635,620.86784,368,940.6737,418,611.12737,568,984.01
其他流动负债3,631,921.23,341,581.312,234,119.432,374,609.79
流动负债平衡项目0000
流动负债合计2,753,663,906.383,409,752,675.792,894,892,103.422,650,540,762.41
非流动负债:
长期借款597,589,001.2245,331,608.6244,539,650251,000,000
递延收益402,590,722.12405,178,272.77391,577,556.78396,881,069.29
非流动负债平衡项目0000
非流动负债合计1,000,179,723.32650,509,881.37636,117,206.78647,881,069.29
负债平衡项目0000
负债合计3,753,843,629.74,060,262,557.163,531,009,310.23,298,421,831.7
所有者权益(或股东权益):
实收资本(或股本)583,378,039583,378,039583,378,039583,278,195
资本公积8,527,876,585.638,525,528,271.828,548,676,086.318,547,963,731.63
减:库存股142,628,826.41126,194,230.07120,259,888.9494,669,527.35
其他综合收益1,576,156.893,652,110.712,852,337.82-5,582,475.57
专项储备10,761,223.6110,799,255.638,751,753.098,751,753.09
盈余公积98,416,146.8698,416,146.8698,029,612.5898,029,612.58
未分配利润2,173,859,737.882,068,601,037.942,016,348,401.591,944,320,933.86
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计11,253,239,063.4611,164,180,631.8911,137,776,341.4511,082,092,223.24
少数股东权益3,610,661,070.073,608,929,570.834,128,965,684.14,112,382,130.07
股东权益平衡项目0000
股东权益合计14,863,900,133.5314,773,110,202.7215,266,742,025.5515,194,474,353.31
负债和股东权益合计18,617,743,763.2318,833,372,759.8818,797,751,335.7518,492,896,185.01
公告日期2024-04-302024-04-302023-10-312023-08-08
审计意见(境内)标准无保留意见
TOP↑